Rydex Nova Adv
9601 Blackwell Road Suite 500 Rockville MD 20850
Map
Phone: 800-820-0888
| Category: | Large Blend | | Fund Family: | Rydex/SGI | | Net Assets: | 8.05M | | Year-to-Date Return: | 21.02% | | Yield: | 0.58% | | Morningstar Rating: |  | | Fund Inception Date: | 15-Oct-98 |
|
Michael P. Byrum
Lead Manager since
15-Oct-98 | | | Byrum is president and CIO of Rydex Investments, his employer since its foundation in 1993. He has ultimate responsibility for the management of the funds. He was named the president of Rydex Investments in 2004 and has served as chief investment officer since 2003.Prior to joining Rydex Investments, Mr. Byrum worked for Money Management Associates, the investment adviser for Rushmore Funds, Inc. Byrum holds the Charted Financial Analyst designation. |
| Min Initial Investment: | $2,500 | | Min Initial Investment, IRA: | $1,000 | | Min Initial Investment, AIP: | NaN | | Min Subsequent Investment: | $0 | | Min Subsequent Investment, IRA: | $0 | | Min Subsequent Investment, AIP: | N/A |
|
| |
| The investment seeks 150% of the performance of the S&P 500 index. The fund employs as its investment strategy a program of investing in the common stock of companies that are generally within the capitalization range of the S&P 500 index and derivative instruments, which primarily consist of equity index swap agreements, futures contracts, and options on securities, futures contracts, and stock indices. It may hold U.S. government securities or cash equivalents to collateralize its derivative positions. The fund is nondiversified. |
| Last Dividend
(4-Dec-08):
| 0.09 | | Last Cap Gain
| YFT_NOT_APPLICABLE_ABBREVIATION | | Annual Holdings Turnover
| 143.00% | | Average for Category:
| 78.94% |
|
| Expense | RYNAX | Category
Avg | | Total Expense Ratio: | 1.79%
| 1.08% | | Max 12b1 Fee: | 0.25%
| N/A | | Max Front End Sales Load: | %
| 5.25% | | Max Deferred Sales Load: | %
| 2.60% | | 3 Yr Expense Projection*: |
$ 563 | $776 | | 5 Yr Expense Projection*: |
$ 970 | $1,291 | | 10 Yr Expense Projection*: |
$ 2,105 | $2,371 |
|
|
0.01% Nasdaq 
0.22%
Profile
